Share chart Johnson & Johnson
Extended chart
Simple chart
About Johnson & Johnson
Johnson & Johnson исследует и разрабатывает, производит и продает ряд продуктов в области здравоохранения по всему миру. Он работает в трех сегментах: потребительское здоровье, фармацевтика и медицинское оборудование. Сегмент Consumer Health предлагает товары для ухода за младенцами под брендами JOHNSON'S и AVEENO Baby; средства по уходу за полостью рта под торговой маркой LISTERINE; товары для красоты и здоровья кожи под маркой AVEENO, CLEAN & CLEAR, DR. more detailsMain settings
IPO date
1944-09-24
ISIN
US4781601046
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
3.4
Дивиденд ао
1.3
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 3.88 | 4 |
| P/BV | 4.83 | 3 |
| P/E | 24.53 | 6 |
Efficiency
| Title | Value | Grade |
| ROA | 8.09 | 3 |
| ROE | 20.06 | 7 |
| ROIC | 19.19 | 6 |
Dividends
| Title | Value | Grade |
| Dividend yield | 3.34 | 8.35 |
| DSI | 0.9286 | 9.29 |
| Average dividend growth | 5.43 | 9.06 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 1.48 | 8 |
| Debt/Ratio | 0.2034 | 10 |
| Debt/Equity | 1.52 | 7 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 7.56 | 1 |
| Yield Ebitda, % | 21.83 | 4 |
| Yield EPS, % | 6.06 | 1 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 157.1 $ | 0 $ | 0 $ | -1.17 % | 0 % | 0 % |
| Week | 155.23 $ | 155.26 $ | 155.26 $ | 0.02 % | 0 % | 0 % |
| Month | 152.94 $ | 147.8 $ | 157.1 $ | 1.52 % | 0 % | 0 % |
| Three month | 148.69 $ | 146.36 $ | 165.84 $ | 4.42 % | 0 % | 0 % |
| Half a year | 154.69 $ | 142.06 $ | 167.7 $ | 0.37 % | 0 % | 0 % |
| Year | 162.95 $ | 142.06 $ | 167.7 $ | -4.72 % | 0 % | 0 % |
| 3 years | 164.76 $ | 142.06 $ | 182.85 $ | -5.77 % | 0 % | 0 % |
| 5 years | 161.91 $ | 136.26 $ | 185.5 $ | -4.11 % | 0 % | 0 % |
| 10 years | 110.99 $ | 90.73 $ | 185.5 $ | 39.89 % | 0 % | 0 % |
| Year to date | 155.26 $ | 142.06 $ | 167.7 $ | 0 % | 0 % | 0 % |
Main owners
Contained in ETF
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Joseph J. Wolk CPA | Executive VP & CFO | 3.17M | 1967 (58 years) |
| Mr. Joaquin Duato | CEO & Chairman | 6.21M | 1963 (62 years) |
| Ms. Jennifer L. Taubert | Executive VP & Worldwide Chairman of Innovative Medicine | 3.1M | 1964 (61 year) |
| Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer | N/A | 1972 (53 years) |
| Mr. James Swanson | Executive VP & Chief Information Officer | N/A | 1966 (59 years) |
| Ms. Jessica Moore | Vice President of Investor Relations | N/A | |
| Mr. Dirk Brinckman | Chief Compliance Officer | N/A | |
| Ms. Elizabeth Forminard | Executive VP & Chief Legal Officer | N/A | 1971 (54 years) |
| Dr. Peter M. Fasolo Ph.D. | Executive VP & Chief Human Resources Officer | 2.15M | 1963 (62 years) |
| Dr. John C. Reed M.D., Ph.D. | Executive Vice President of Innovative Medicine, R&D | 8.57M | 1958 (67 years) |
About company
Address: United States, New Brunswick, One Johnson & Johnson Plaza - Open in google maps, Open in yandex maps
Website: http://www.jnj.com
Website: http://www.jnj.com
